TAKE 5 To discover dbs therapy for your parkinson's patients

April 11th is World Parkinson’s Day

This year again, we are collaborating with the EPDA (European Parkinson’s Disease Association) to raise awareness of Parkinson’s disease – a chronic and progressive movement disorder, in which symptoms worsen over time. It affects over 6 million people worldwide - a number that will double by 2040.¹

There are therapies to help people with Parkinson’s as their condition progresses – Deep Brain Stimulation has been proven effective at helping people with Parkinson’s.²

Learn More about DBS as an advanced therapy

The window of opportunity for your patients to receive DBS therapy begins as early as 5 years after the appearance of their first Parkinson’s symptoms.3

Knowing when to have the conversation about further treatment options can make a significant difference in your patients’ quality of life.⁴

When is a good time to consider DBS Therapy for your patients?⁴

Use the Medtronic EarlyStimulus tool to refer with confidence

Visit Earlystimulus site

Image of the Earlystimulus website on a tablet

With the guidance of the Medtronic EarlyStimulus tool, you'll have actionable, objective information at your fingertips to inform the therapeutic decisions you make with your patients.

Clinical studies supporting the use of DBS therapy 175,000 patients* treated worldwide

Read the compendium

Image of Percept device, alongside HCP and patient programmers

Discover how DBS Therapy can help your patients

View DBS products

Discover Percept^TM PC neurostimulator with BrainSense^TM Technology

DOWNLOAD BROCHURE

Talk to us about DBS therapy for Parkinson's

Fill in the form below to have a Medtronic representative contact you.

*Indicates Required Field

Please select at least one option below:*

I would like to be contacted by a Medtronic representative

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

References

European Parkinson’s Disease Association. “What Is Parkinson’s?” Accessed December 10, 2020. https://www.epda.eu.com/about-parkinsons/what-is-parkinsons/.

Schüpbach W, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. EARLYSTIM Study. N Eng J Med. 2013;368:610-622.

WebMD. “Deep Brain Stimulation for Parkinson’s Disease.” Accessed December 10, 2020. https://www.webmd.com/parkinsons-disease/guide/dbs-parkinsons.

⁴

Okun MS, Foote KD. Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother. 2010 December ; 10(12): 1847–1857.

Number of unique patients implanted as of January 2020.

Brief statement

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu